This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
1 Citations
Facts about Indoleamine 2,3-dioxygenase 2.
May not play a substantial role in tryptophan-related tumoral immunity (PubMed:25691885). .
| Human | |
|---|---|
| Gene Name: | IDO2 |
| Uniprot: | Q6ZQW0 |
| Entrez: | 169355 |

| Belongs to: |
|---|
| indoleamine 2,3-dioxygenase family |

EC 1.13.11.-; IDO2; Ido-2; INDOL1; INDOL1indoleamine-pyrrole 2,3 dioxygenase-like 1; indoleamine 2,3-dioxygenase 2; Indoleamine 2,3-dioxygenase-2; indoleamine 2,3-dioxygenase-like 1 protein; Indoleamine 2,3-dioxygenase-like protein 1; Indoleamine-pyrrole 2,3-dioxygenase-like protein 1
Mass (kDA):
47.075 kDA

| Human | |
|---|---|
| Location: | 8p11.21 |
| Sequence: | 8; NC_000008.11 (39934955..40016391) |
Detected in liver, small intestine, spleen, placenta, thymus, lung, brain, kidney, and colon (PubMed:17671174). Also expressed at low level in testis and thyroid. Not expressed in the majority of human tumor samples (>99%) (PubMed:25691885).



PMID: 17499941 by Ball H.J., et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.
PMID: 17671174 by Metz R., et al. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.